Skip to main content
David Adelstein, MD, Oncology, Cleveland, OH, Cleveland Clinic

DavidJAdelsteinMD

Oncology Cleveland, OH

Co-Chairman, National Cancer Institute Head and Neck Cancer Steering Committee, Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University

Dr. Adelstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Adelstein's full profile

Already have an account?

Education & Training

  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 1978 - 1981
  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1975 - 1979
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineClass of 1975
  • University of Chicago
    University of ChicagoB.A., 1968 - 1971

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1990 - 1991
  • OH State Medical License
    OH State Medical License 1977 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Directors Service Award National Cancer Institute, 2011, 2013
  • Teacher of the Year: Department of Solid Tumor Oncology Taussig Cancer Institute, Cleveland Clinic, 2009-2010
  • Teacher of the Year: Department of Hematology and Medical Oncology Cleveland Clinic Foundation, 2001-2002
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-Term Outcomes and Toxicity  
    Brian B Burkey, Neil M Woody, John F Greskovich, David J Adelstein, Aditya Juloori, Shlomo A Koyfman, Joseph Scharpf, Brandon Prendes, Anticancer Research
  • Its not just IMRT: Human papillomavirus related oropharynx squamous cell carcinoma is associated with better swallowing outcomes after definitive chemoradiotherapy  
    Naik M, Ward MC, Bledsoe TJ, Kumar AMS, Rybicki LA, Saxton JP, Burkey BB, Greskovich JF, Koyfman SA, Oral Oncology, 1/1/2016
  • Prospective clinical study of precision oncology in solid tumors  
    Sohal DPS, Rini BI, Khorana AA, Dreicer R, Abraham J, Procop GW, Saunthararajah Y, Pennell NA, Stevenson JP, Pelley R, Estfan B, Shepard D, Funchain P, Elson P, Adelst..., Journal of the National Cancer Institute, 1/1/2016
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Measuring impact of survivorship care plans on head and neck cancer patients
    Harr BA, Bodmann J, Koyfman SA, Nwizu TI, Joshi NP, Ives DI, Rahe ML, Hamker JF, Journal of Clinical Oncology, 1/1/2016
  • Pathologic and clinical outcomes in cT2N0 esophageal cancer: A cohort study
    Bhuchar G, Altujjar M, Raja S, Murthy SC, Raymond D, Videtic GMM, McNamara MJ, Khorana AA, Sohal D, Journal of Clinical Oncology, 1/1/2016
  • The impact of persistent dysphagia (PD) after induction chemotherapy in patients with loco-regionally advanced (LRA) adenocarcinoma (ACA) of the esophagus and gastro-e...
    McNamara MJ, Rybicki LA, Rodriguez CP, Videtic GMM, Stephans KL, Greskovich J, Sohal D, Murthy SC, Raja S, Ives DI, Bodmann J, Journal of Clinical Oncology, 1/1/2015
  • Join now to see all

Lectures

  • Hematology and Medical Oncology Board Review Course 
    George Washington University, Washington, Dist Of Col - 8/15/2013

Press Mentions

  • ASCO: Deintensified Treatment in p16+ Oropharyngeal Cancer Needs Evaluation
    ASCO: Deintensified Treatment in p16+ Oropharyngeal Cancer Needs EvaluationMay 2nd, 2019

Grant Support

  • Southwest Oncology GroupNational Cancer Institute1993

Professional Memberships

Hospital Affiliations